Cargando…

Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity

Multidrug-resistant tuberculosis (MDR-TB) poses a significant threat to mankind and as such earned its place on the WHO list of priority pathogens. New antimycobacterials with a mechanism of action different to currently used agents are highly required. This study presents the design, synthesis, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pallabothula, Vinod Sukanth Kumar, Kerda, Marek, Juhás, Martin, Janďourek, Ondřej, Konečná, Klára, Bárta, Pavel, Paterová, Pavla, Zitko, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687610/ https://www.ncbi.nlm.nih.gov/pubmed/36358911 http://dx.doi.org/10.3390/biom12111561

Ejemplares similares

Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity
por: Bouz, Ghada, et al.
Publicado: (2019)

5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
por: Ambrożkiewicz, Weronika, et al.
Publicado: (2020)

3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation
por: Semelková, Lucia, et al.
Publicado: (2017)

Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole
por: Juhás, Martin, et al.
Publicado: (2022)

Correction: Juhás et al. Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals 2022, 15, 580
por: Juhás, Martin, et al.
Publicado: (2023)

N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—the Synthesis and Biological Evaluation of Enantiomers
por: Juhás, Martin, et al.
Publicado: (2020)

Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents
por: Zitko, Jan, et al.
Publicado: (2018)

Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase
por: Šlechta, Petr, et al.
Publicado: (2023)

Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation
por: Jandourek, Ondrej, et al.
Publicado: (2017)

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids
por: Semelková, Lucia, et al.
Publicado: (2017)

Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides
por: Bouz, Ghada, et al.
Publicado: (2021)

Synthesis, Antimycobacterial Activity and In Vitro Cytotoxicity of 5-Chloro-N-phenylpyrazine-2-carboxamides
por: Zitko, Jan, et al.
Publicado: (2013)

Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies
por: Pang, Luping, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides
por: Semelkova, Lucia, et al.
Publicado: (2015)

Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies
por: Bouz, Ghada, et al.
Publicado: (2019)

Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
por: Doležal, Martin, et al.
Publicado: (2009)

A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Antimycobacterial Activity
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Synthesis, Antimycobacterial, Antifungal and Photosynthesis-Inhibiting Activity of Chlorinated N-phenylpyrazine-2-carboxamides †
por: Dolezal, Martin, et al.
Publicado: (2010)

Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors
por: Bouz, Ghada, et al.
Publicado: (2017)

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
por: Keller, Tracy L., et al.
Publicado: (2012)

Evolution of acceptor stem tRNA recognition by class II prolyl-tRNA synthetase
por: An, Songon, et al.
Publicado: (2008)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
por: Tye, Mark A., et al.
Publicado: (2022)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents
por: Maafi, Negar, et al.
Publicado: (2021)

Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease
por: Lee, Eun-Young, et al.
Publicado: (2023)

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1
por: Yoon, Ina, et al.
Publicado: (2023)

Strictly Conserved Lysine of Prolyl-tRNA Synthetase Editing Domain Facilitates Binding and Positioning of Misacylated tRNA(Pro)
por: Bartholow, Thomas G., et al.
Publicado: (2014)

Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents
por: Wijaya, Viriyanata, et al.
Publicado: (2022)

New Potentially Active Pyrazinamide Derivatives Synthesized Under Microwave Conditions
por: Jandourek, Ondrej, et al.
Publicado: (2014)

The zinc-binding domain of mammalian prolyl-tRNA synthetase is indispensable for catalytic activity and organism viability
por: Vasu, Kommireddy, et al.
Publicado: (2021)

Glutamyl-prolyl-tRNA synthetase 1 coordinates early endosomal anti-inflammatory AKT signaling
por: Lee, Eun-Young, et al.
Publicado: (2022)

Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome
por: Sofou, Kalliopi, et al.
Publicado: (2015)

Adenosine-Dependent Activation Mechanism of Prodrugs Targeting an Aminoacyl-tRNA Synthetase
por: Hoffmann, Guillaume, et al.
Publicado: (2023)

Substituted N-Benzylpyrazine-2-carboxamides: Synthesis and Biological Evaluation (†)
por: Servusová, Barbora, et al.
Publicado: (2012)

Origin and Evolution of Glutamyl-prolyl tRNA Synthetase WHEP Domains Reveal Evolutionary Relationships within Holozoa
por: Ray, Partho Sarothi, et al.
Publicado: (2014)

Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
por: Hewitt, Stephen Nakazawa, et al.
Publicado: (2016)

Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy
por: Shibata, Akira, et al.
Publicado: (2017)

Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development
por: Manickam, Yogavel, et al.
Publicado: (2022)

Cardiomyocyte-specific Loss of Glutamyl-prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy
por: Wu, Jiangbin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33ipc3gccpr9lalqajtfeqvee9